1) Adler CH, Connor DJ, Hentz JG, et al:Incidental Lewy body disease:Clinical comparison to a control cohort. Mov Disord 25:642-646, 2010
2) den Brok MG, van Dalen JW, van Gool WA, et al:Apathy in Parkinson's disease:A systematic review and meta-analysis. Mov Disord 30:759-769, 2015
3) Dubois B, Burn D, Goetz C, et al:Diagnostic procedures for Parkinson's disease dementia:Recommendations from the movement disorder society task force. Mov Disord 22:2314-2324, 2007
4) Fritze F, Ehrt U, Hortobagyi T, et al:Depressive symptoms in Alzheimer's disease and Lewy body dementia:A one-year follow-up study. Dement Geriatr Cogn Disord 32:143-149, 2011
5) Homburger A:Motorik. In:Bumke O, ed. Die Schizophrenie. Handbuch Der Geisteskrankheiten. Springer Verlag, Berlin, pp211-264, 1933
6) Huang Y, Halliday G:Can we clinically diagnose dementia with Lewy bodies yet? Transl Neurodegener 2:4, 2013. doi:10.1186/2047-9158-2-4
7) Hughes AJ, Daniel SE, Kilford L, et al:Accuracy of clinical diagnosis of idiopathic Parkinson's disease:A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184, 1992
8) Iritani S, Tsuchiya K, Arai T, et al:An atypical autopsy case of Lewy body disease with clinically diagnosed major depression:A clinical, radiological and pathological study. Neuropathology 28:652-659, 2008
9) Klein C, Kömpf D, Pulkowski U, et al:A study of visual hallucinations in patients with Parkinson's disease. J Neurol 244:371-377, 1997
10) Kobayashi K, Sumiya H, Nakano H, et al:Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy. Int J Geriatr Psychiatry 25:55-65, 2010
11) Kobayashi K, Nakano H, Akiyama N, et al:Pure psychiatric presentation of the Lewy body disease is depression-an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study. Int J Geriatr Psychiatry 30:663-668, 2015
12) Lemke MR:Depressive symptoms in Parkinson's disease. Eur J Neurol 15 (Suppl):S21-S25, 2008
13) Lennox GG:Dementia with Lewy bodies. In:Growdon JH, Rosser MN, ed. The Dementias. Butterworth-Heinemann, Woburn, pp67-79, 1998
14) Lieberman A:Are dementia and depression in Parkinson's disease related? J Neurol Sci 248:138-142, 2006
15) McKeith IG, Dickson DW, Lowe J, et al:Diagnosis and management of dementia with Lewy bodies:Third report of the DLB consortium. Neurology 65:1863-1872, 2005
16) Navarro-Otano J, Gelpi E, Mestres CA, et al:Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism. Parkinsonism Relat Disord 19:27-31, 2013
17) Pagonabarraga J, Kulisevsky J, Strafella AP, et al:Apathy in Parkinson's disease:Clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 14:518-531, 2015
18) Peralta V, Basterra V, Campos MS, et al:Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders. Eur Arch Psychiatry Clin Neurosci 262:131-138, 2012
19) Pfeiffer RF:Non-motor Parkinsonism. Parkinsonism Relat Disord 13 (Suppl 3):S211-S220, 2007
20) Prasad K, Beach TG, Hedreen J, et al:Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease. Brain Pathol 22:811-825, 2012
21) Rai NK, Goyal V, Kumar N, et al:Neuropsychiatric co-morbidities in non-demented Parkinson's disease. Ann Indian Acad Neurol 18:33-38, 2015
22) Sakakibara R, Ogata T, Haruta M, et al:Amnestic mild cognitive impairment with low myocardial metaiodobenzylguanidine uptake. Am J Neurodegener Dis 1:146-151, 2012
23) Stefanis N, Bozi M, Christodoulou C, et al:Isolated delusional syndrome in Parkinson's disease. Parkinsonism Relat Disord 16:550-552, 2010
24) Tateno F, Sakakibara R, Kishi M, et al:Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic. Parkinsonism Relat Disord 17:395-397, 2011